Cingulate stock skyrockets after ADHD treatment shows positive trial results

Shares of Cingulate Inc. CING, +51.30% skyrocketed 82.9% toward an 11-month high in active premarket trading Friday, after the biopharmaceutical company reported positive results from a trial of its a...

Low Supplies Of Adderall And Prescription Startups Fueled Crisis

Topline Ritalin is the latest attention deficit hyperactivity disorder (ADHD) medication in short supply—after a months-long Adderall shortage—leaving patients who rely on these drugs to manage daily ...

Increased demand for ADHD medication straining U.S. health-care system

Stories about attention deficit hyperactivity disorder, or ADHD, have been having a resurgence in the social media zeitgeist the past several years, and it may be leading more people to seek out diagn...